Tirzepatide-induced ketoacidosis with hyperglycemia in a patient without diabetes
Artículo
Acceso abierto
Artículo
DOAJ
Abstract Tirzepatide,a dual GLP-1 and GIP receptor agonist, is increasingly used for weight management in both patients with diabetes and patients without diabetes. While gastrointestinal side effects such as nausea are ...
LCC LCC:Medicine; LCC:Diseases of the endocrine glands. Clinical endocrinologyIdioma eng
Acceso abiertoRuta libre sin proxy. Acceso recomendado cuando no hay suscripción activa.
Open Access